Grant and Research Support

GRANT AND RESEARCH SUPPORT

Discover
HEMA Biologics

HEMA Biologics Grants/Investigator Initiated Studies

HEMA Biologics is committed to improving patient care and will consider providing financial support to institutions (e.g. academic), associations (e.g. medical professionals or patients) or recognized third party medical education providers of independent medical education programs and resources that address healthcare knowledge gaps and provide non-promotional information to patients and/or healthcare providers.

We support high quality, independent education through unrestricted educational grants focused on enhancing medical professional and patient awareness, knowledge and education. Supported programs must be objective, balanced and scientifically rigorous. In addition, programs must be in full compliance with applicable laws, regulations, and guidelines, including those established by relevant regulatory agencies and industry associations. Applications can be submitted online at any time, all year round. Please be sure to apply well in advance of your funding needs because the application review process can take from 8 to 16 weeks.

Examples of programs that may be considered for funding:

  • Independent, accredited and non-accredited programs that foster increased understanding of scientific, clinical, and healthcare issues and contribute to the enhancement of patient care.
  • Independent development of educational tools or resources to enhance physician-patient dialogue about treatment of disease.
  • Support of independent projects that lead to measurable improvements in healthcare services and health status of individuals and targeted patient groups and do not relate to a HEMA Biologics asset.
  • Support for producing educational material for patients in an independent way.
  • Support for the development and running of a patient registry

HEMA Biologics will also consider innovative ideas that enhance patient care and advance scientific knowledge.

Request for Proposals

HEMA Biologics is seeking to receive study proposals for the following therapeutic areas of interest in Rare Bleeding Disorders or for the control of refractory bleeding in non-hemophilia patients. Please click on the RFP to see specific criteria and parameters for that specific area of interest.

Medical Education Grants Proposal

What is this?

As part of our goal to help those living with rare bleeding disorders, we are strongly committed to supporting independent medical education activities.

Requirements for submission:

Download List of Required Documentation (.pdf)

How to submit application:
Completed educational grant request applications should be sent electronically to our Medical Affairs Department grants@hemabio.com.

Investigator-Initiated Research (IIR) Proposal

What is this?

Key scientific insights often come from clinical settings where the full spectrum of disease is manifest. Providing support for clinical scientists performing unsolicited, independent research projects is part of our commitment to helping those with rare bleeding disorders.

Requirements for submission:

RFP documentation IIS Downloadable Form (.pdf)

Download list of Required Documentation (.pdf)

How to submit application:
Email all required documents to grants@hemabio.com.

General Guidelines for Medical Educational Grant Requests and IIR Proposals

HEMA Biologics will acknowledge the receipt of all requests and proposals within 5 business days. If you have not heard from HEMA Biologics within this time frame, do not hesitate to contact Medical Affairs at 855-717-HEMA (4362).

Support by HEMA Biologics of independent educational activities is limited to only those that fall within the company's specific area of therapeutic focus, to treat rare bleeding disorders.

Only fully-completed educational grant applications and investigator-initiated research proposals will be reviewed, and completing the application does not guarantee approval nor financial support in the entire amount being requested.

The contact person at the requesting organization will be notified within 3 months of receipt of the application with the approval or denial status. Therefore, it is recommended that funding requests be submitted at least 3 months prior to the date of the event, as applicable, to ensure sufficient time for internal review.

If HEMA Biologics is able to provide funding for the educational activity, a Letter of Agreement (provided by HEMA Biologics) must be signed by the Educational Provider and HEMA Biologics.

Any activity for which a grant or investigator-initiated research proposal is awarded is required to be compliant with and adhere to federal and state guidelines and regulations, including, but not limited to, the FDA Final Guidance on Industry-Supported Scientific and Educational Activities, the Accreditation Council for Continuing Medical Education (ACCME) Standards for Commercial Support, the American Medical Association (AMA) Ethical Guidelines for Gifts to Physicians from Industry, and the Pharmaceutical Research and Manufacturers of America (PhRMA) Code on Interactions with Healthcare Professionals, where applicable.